Prolonged treatment for acute symptomatic refractory status epilepticus
- 12 August 2003
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 61 (3) , 398-401
- https://doi.org/10.1212/01.wnl.0000073139.53008.f2
Abstract
High-dose suppressive therapy (HDST) is used to treat refractory status epilepticus (RSE). Prolonged therapy is required in some cases, and prognosis is important in making therapeutic decisions. The authors therefore studied the long-term outcome in previously normal children who survived prolonged HDST for acute symptomatic RSE. All have intractable epilepsy, and none returned to baseline.Keywords
This publication has 9 references indexed in Scilit:
- Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic ReviewEpilepsia, 2002
- Outcome of Severe Refractory Status Epilepticus in ChildrenEpilepsia, 2001
- Neurologic outcomes of pediatric epileptic patients with pentobarbital comaPediatric Neurology, 2001
- Prolonged Treatment of Refractory Status Epilepticus in a ChildJournal of Child Neurology, 2001
- Does Status Epilepticus in Children Cause Developmental Deterioration and Exacerbation of Epilepsy?Journal of Child Neurology, 1999
- Efficacy and Mortality in Treatment of Refractory Generalized Convulsive Status Epilepticus in Children: A Meta-AnalysisJournal of Child Neurology, 1999
- Relapse and Survival After Barbiturate Anesthetic Treatment of Refractory Status EpilepticusEpilepsia, 1996
- Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticusCritical Care Medicine, 1995
- Advances in the management of refractory status epilepticusCritical Care Medicine, 1993